The Daily

'Some Hope Is Better Than Having No Hope'

07.07.2021 - By The New York TimesPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

When the F.D.A. approved the drug Aduhelm, the first Alzheimer’s treatment to receive the agency’s endorsement in almost two decades, it gave hope to many.

But the decision was contentious; some experts say there’s not enough evidence that the treatment can address cognitive symptoms.

What is the story behind this new drug?

Guest: Pam Belluck, a health and science writer for The New York Times.

More episodes from The Daily